BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15536619)

  • 1. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies.
    Do KA; Johnson MM; Lee JJ; Wu XF; Dong Q; Hong WK; Khuri FR; Spitz MR
    Cancer; 2004 Dec; 101(12):2837-42. PubMed ID: 15536619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States).
    Do KA; Johnson MM; Doherty DA; Lee JJ; Wu XF; Dong Q; Hong WK; Khuri FR; Fu KK; Spitz MR
    Cancer Causes Control; 2003 Mar; 14(2):131-8. PubMed ID: 12749718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?
    Choi SH; Terrell JE; Bradford CR; Ghanem T; Spector ME; Wolf GT; Lipkus IM; Duffy SA
    Nicotine Tob Res; 2016 Dec; 18(12):2216-2224. PubMed ID: 27613928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
    Bhatia AK; Lee JW; Pinto HA; Jacobs CD; Limburg PJ; Rubin P; Arusell RM; Dunphy EP; Khandekar JD; Reiner SA; Baez-Diaz L; Celano P; Li S; Li Y; Burtness BA; Adams GL; Pandya KJ
    Cancer; 2017 Dec; 123(23):4653-4662. PubMed ID: 28786105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
    Lippman SM; Lee JJ; Karp DD; Vokes EE; Benner SE; Goodman GE; Khuri FR; Marks R; Winn RJ; Fry W; Graziano SL; Gandara DR; Okawara G; Woodhouse CL; Williams B; Perez C; Kim HW; Lotan R; Roth JA; Hong WK
    J Natl Cancer Inst; 2001 Apr; 93(8):605-18. PubMed ID: 11309437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second head and neck cancers and tobacco usage.
    Tomek MS; McGuirt WF
    Am J Otolaryngol; 2003; 24(1):24-7. PubMed ID: 12579479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer.
    Wu X; Zhao H; Do KA; Johnson MM; Dong Q; Hong WK; Spitz MR
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3988-95. PubMed ID: 15217929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of long-term smoking cessation in head and neck cancer patients.
    Gritz ER; Carr CR; Rapkin D; Abemayor E; Chang LJ; Wong WK; Belin TR; Calcaterra T; Robbins KT; Chonkich G
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):261-70. PubMed ID: 8318879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.
    Gan SJ; Dahlstrom KR; Peck BW; Caywood W; Li G; Wei Q; Zafereo ME; Sturgis EM
    Cancer; 2013 Jul; 119(14):2593-601. PubMed ID: 23605777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study.
    Bugter O; van Iwaarden DLP; van Leeuwen N; Nieboer D; Dronkers EAC; Hardillo JAU; Baatenburg de Jong RJ
    Head Neck; 2021 Jun; 43(6):1881-1889. PubMed ID: 33655596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
    Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
    Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature.
    von Kroge PR; Bokemeyer F; Ghandili S; Bokemeyer C; Seidel C
    Oncol Res Treat; 2020; 43(10):549-558. PubMed ID: 32950990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Modality and Second Primary Tumors of the Head and Neck.
    Ben Arie G; Shafat T; Belochitski O; El-Saied S; Joshua BZ
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(6):420-427. PubMed ID: 34587611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma.
    Dikshit RP; Boffetta P; Bouchardy C; Merletti F; Crosignani P; Cuchi T; Ardanaz E; Brennan P
    Cancer; 2005 Jun; 103(11):2326-33. PubMed ID: 15852357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second primary tumors in laryngeal cancer: results of long-term follow-up.
    Narayana A; Vaughan AT; Fisher SG; Reddy SP
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):557-62. PubMed ID: 9806515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking status and symptom burden in surgical head and neck cancer patients.
    Sterba KR; Garrett-Mayer E; Carpenter MJ; Tooze JA; Hatcher JL; Sullivan C; Tetrick LA; Warren GW; Day TA; Alberg AJ; Weaver KE
    Laryngoscope; 2017 Jan; 127(1):127-133. PubMed ID: 27392821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical characteristics of secondary primary tumors in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy: A retrospective analysis.
    Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X; Wang X
    Medicine (Baltimore); 2016 Nov; 95(45):e5364. PubMed ID: 27828863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck.
    Fortin A; Wang CS; Vigneault E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1062-9. PubMed ID: 19036528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.